| Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart. | |
| | |
MedLine Citation:
|
PMID: 8877776 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The present study was undertaken to determine whether trandolaprilat, an active form of angiotensin I converting enzyme (ACE) inhibitor, may improve ischemia/reperfusion-induced contractile dysfunction and metabolic derangement of isolated rat hearts. Ischemia (25 min) and subsequent 60-min reperfusion resulted in a small recovery of post-ischemic left ventricular developed pressure (LVDP), a sustained increase in left ventricular end-diastolic pressure, an increase in the release of creatine kinase and ATP metabolites from the perfused heart, and changes in myocardial sodium, potassium, calcium and magnesium contents. Treatment with 10-100 microM of trandolaprilat for the last 10 min of pre-ischemia recovered approximately 50-90% of pre-ischemic LVDP during reperfusion, whereas that with 30-100 microM of enalaprilat restored approximately 55-65% of the pre-ischemic LVDP. Treatment with either trandolaprilat or enalaprilat at these concentrations attenuated the release of creatine kinase and ATP metabolites into the perfusate during reperfusion. Treatment with 30 microM trandolaprilat suppressed ischemia/reperfusion-induced changes in myocardial ion content. Treatment with bradykinin during the last 10 min of pre-ischemia also resulted in a post-ischemic contractile recovery with a degree similar to that of the trandolaprilat-treated hearts. E4177, an AT1-antagonist, showed no effect on ischemia/reperfusion-induced changes in cardiac parameters. The enhancement of post-ischemic contractile recovery by the ACE inhibitor was abolished by treatment with either Hoechst 140, a bradykinin (BK2) antagonist, or diclofenac, a cyclooxygenase inhibitor. These results suggest that trandolaprilat is capable of attenuating ischemia/reperfusion injury of isolated perfused hearts and altered BK metabolism is, at least in part, involved in this effect. |
| | |
Authors:
|
K Tanonaka; T Kamiyama; A Takezono; K Sakai; S Takeo |
Related Documents
:
|
8895266 - Thoracic epidural anesthesia improves functional recovery from myocardial stunning in c... 1314716 - Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hy... 3183946 - Thromboxane a2 antagonist and diltiazem-induced enhancement of contractile function: th... 10443616 - Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postisch... 6692656 - Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. 23178426 - Circadian variation of blood pressure and heart rate in normotensives, white-coat, mask... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of molecular and cellular cardiology Volume: 28 ISSN: 0022-2828 ISO Abbreviation: J. Mol. Cell. Cardiol. Publication Date: 1996 Aug |
Date Detail:
|
Created Date: 1997-01-29 Completed Date: 1997-01-29 Revised Date: 2003-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0262322 Medline TA: J Mol Cell Cardiol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 1659-70 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Hachioji, Japan. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenosine Triphosphate
/
metabolism Analysis of Variance Angiotensin-Converting Enzyme Inhibitors / therapeutic use* Animals Bradykinin / pharmacology Cations / metabolism Creatine Kinase / metabolism Enalaprilat / pharmacology Indoles / therapeutic use* Male Myocardial Contraction / drug effects* Myocardial Reperfusion Injury / drug therapy* Rats Rats, Wistar Receptors, Angiotensin / antagonists & inhibitors Receptors, Bradykinin / antagonists & inhibitors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Cations; 0/Indoles; 0/Receptors, Angiotensin; 0/Receptors, Bradykinin; 56-65-5/Adenosine Triphosphate; 58-82-2/Bradykinin; 83601-86-9/trandolaprilat; 84680-54-6/Enalaprilat; EC 2.7.3.2/Creatine Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Expression of phenylethanolamine n-methyltransferase in the embryonic rat heart.
Next Document: Importance of the early alterations of energy metabolism in the induction and the disappearance of i...